Integer Holdings Corp. (ITGR) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

433.92 k

Shareholding (Mar 2025)

FII

11.37%

Held by 120 FIIs

DII

25.18%

Held by 68 DIIs

Promoter

1.93%

How big is Integer Holdings Corp.?

22-Jun-2025

As of Jun 18, Integer Holdings Corp. has a market capitalization of $4.15 billion, with net sales of $1.76 billion and a net profit of $78.04 million over the last four quarters.

What does Integer Holdings Corp. do?

22-Jun-2025

Integer Holdings Corporation is a medical device outsourcing manufacturer in the Pharmaceuticals & Biotechnology industry, with a market cap of approximately USD 4.15 billion. As of March 2025, it reported net sales of USD 436 million and a net profit of -USD 22 million.

Who are in the management team of Integer Holdings Corp.?

22-Jun-2025

As of March 2022, the management team of Integer Holdings Corp. includes Bill Sanford (Independent Chairman), Joseph Dziedzic (CEO), and several independent directors: Pamela Bailey, James Hinrichs, Jean Hobby, Martin Maxwell, and Filippo Passerini. They oversee the company's strategic direction and operations.

Is Integer Holdings Corp. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Integer Holdings Corp. is in a bearish trend, with negative indicators across multiple technical analyses, and has underperformed the S&P 500 significantly, showing a year-to-date return of -44.98%.

Is Integer Holdings Corp. overvalued or undervalued?

11-Nov-2025

As of November 7, 2025, Integer Holdings Corp. is considered overvalued with a valuation grade of "expensive," reflected by a high P/E ratio of 45 and a year-to-date stock performance of -48.11%, significantly underperforming the S&P 500's 14.40% return.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor long term growth as Operating profit has grown by an annual rate 8.76% of over the last 5 years

The company declared negative results in Mar'25 after positive results in Dec'24

With ROCE of 8.55%, it has a very expensive valuation with a 1.93 Enterprise value to Capital Employed

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 3,721 Million (Small Cap)

P/E

45.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.70

Return on Equity

5.31%

Price to Book

2.18

Revenue and Profits:

Net Sales:

473 Million

(Quarterly Results - Jun 2025)

Net Profit:

37 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-33.75%

6 Months

-41.23%

1 Year

-49.74%

2 Years

-20.98%

3 Years

-3.55%

4 Years

-11.98%

5 Years

-10.16%

Integer Holdings Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Integer Holdings Corp. overvalued or undervalued?

As of 7 November 2025, the valuation grade for Integer Holdings Corp. has moved from very expensive to expensive, indicating a shift in perception regarding its valuation. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 45, a Price to Book Value of 2.63, and an EV to EBITDA ratio of 15.31. In comparison, Sanmina Corp., a peer, has a more attractive P/E ratio of 39.80, suggesting that Integer Holdings Corp. is trading at a premium relative to its industry peers. The company's recent stock performance has been notably poor, with a year-to-date return of -48.11%, significantly underperforming the S&P 500, which has returned 14.40% in the same period. This stark contrast further supports the conclusion that Integer Holdings Corp. is overvalued in the current market environment....

Is Integer Holdings Corp. overvalued or undervalued?

As of 7 November 2025, the valuation grade for Integer Holdings Corp. has moved from very expensive to expensive, indicating a shift in perception regarding its valuation. The company appears to be overvalued based on its current metrics, which include a P/E ratio of 45, a Price to Book Value of 2.63, and an EV to EBITDA of 15.31. In comparison, Sanmina Corp., a peer in the same industry, has a more attractive P/E ratio of 39.80 and an EV to EBITDA of 22.21, suggesting that Integer Holdings Corp. is trading at a premium relative to its peers. The recent stock performance further reinforces this valuation perspective, as Integer Holdings Corp. has experienced a significant decline of 49.28% over the past year, while the S&P 500 has gained 12.65% in the same period. This stark contrast highlights the challenges the company faces in maintaining investor confidence amidst its high valuation ratios....

Is Integer Holdings Corp. technically bullish or bearish?

As of 24 October 2025, the technical trend for Integer Holdings Corp. has changed from mildly bearish to bearish. The weekly MACD is bearish, and the daily moving averages also indicate a bearish stance. The Bollinger Bands are bearish on both weekly and monthly time frames. Although the weekly RSI shows bullish momentum, it is not supported by other indicators, such as the KST and Dow Theory, which are bearish or show no trend. In terms of performance, the stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -44.98% versus the S&P 500's 15.47%. Overall, the current technical stance is bearish and indicates weakness in the stock's performance....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.37%

EBIT Growth (5y)

8.76%

EBIT to Interest (avg)

3.68

Debt to EBITDA (avg)

3.75

Net Debt to Equity (avg)

0.75

Sales to Capital Employed (avg)

0.62

Tax Ratio

28.87%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

6.40%

ROE (avg)

5.72%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.63

EV to EBIT

22.59

EV to EBITDA

15.31

EV to Capital Employed

1.93

EV to Sales

3.10

PEG Ratio

Dividend Yield

ROCE (Latest)

8.55%

ROE (Latest)

5.83%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 97 Schemes (61.44%)

Foreign Institutions

Held by 120 Foreign Institutions (11.37%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 8.29% vs 9.20% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 18.59% vs 30.00% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "472.80",
          "val2": "436.60",
          "chgp": "8.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "85.00",
          "val2": "87.90",
          "chgp": "-3.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.60",
          "val2": "15.30",
          "chgp": "-37.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.50",
          "val2": "-6.00",
          "chgp": "191.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.00",
          "val2": "31.20",
          "chgp": "18.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "111.50%",
          "val2": "139.00%",
          "chgp": "-2.75%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.62% vs 12.81% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 35.91% vs 36.45% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,719.80",
          "val2": "1,554.70",
          "chgp": "10.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "339.80",
          "val2": "255.90",
          "chgp": "32.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "56.40",
          "val2": "52.50",
          "chgp": "7.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-23.30",
          "val2": "-7.50",
          "chgp": "-210.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "121.10",
          "val2": "89.10",
          "chgp": "35.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "135.30%",
          "val2": "103.10%",
          "chgp": "3.22%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

472.80

436.60

8.29%

Operating Profit (PBDIT) excl Other Income

85.00

87.90

-3.30%

Interest

9.60

15.30

-37.25%

Exceptional Items

5.50

-6.00

191.67%

Consolidate Net Profit

37.00

31.20

18.59%

Operating Profit Margin (Excl OI)

111.50%

139.00%

-2.75%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 8.29% vs 9.20% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 18.59% vs 30.00% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,719.80

1,554.70

10.62%

Operating Profit (PBDIT) excl Other Income

339.80

255.90

32.79%

Interest

56.40

52.50

7.43%

Exceptional Items

-23.30

-7.50

-210.67%

Consolidate Net Profit

121.10

89.10

35.91%

Operating Profit Margin (Excl OI)

135.30%

103.10%

3.22%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 10.62% vs 12.81% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 35.91% vs 36.45% in Dec 2023

All Annual Results

Company CV

About Integer Holdings Corp.

Integer Holdings Corp.

Pharmaceuticals & Biotechnology

Integer Holdings Corporation, formerly Greatbatch, Inc., is a medical device outsource manufacturing company. The Company's segments include Medical and Non-Medical. Medical segment includes Portable Medical, Cardio & Vascular, and Cardiac & Neuromodulation product lines. Non-Medical segment includes Electrochem product line. It serves the cardiac, neuromodulation and vascular markets. It also serves the non-medical power solutions market. In addition, the Company develops batteries for niche applications in energy, military, and environmental markets. Its brands include Greatbatch Medical, Lake Region Medical and Electrochem. Its primary customers include multi-national original equipment manufacturers (OEMs) and their affiliated subsidiaries.

Company Coordinates

Company Details

5830 Granite Parkway., Suite 1150 , PLANO TX : 75024

Tel: 1 302 65875811 716 7595809

https://integer.net

Registrar Details

Integer Holdings Corp.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Integer Holdings Corp.?

Watch in Real-Time

What does Integer Holdings Corp. do?

Who are in the management team of Integer Holdings Corp.?

Is Integer Holdings Corp. technically bullish or bearish?

Is Integer Holdings Corp. overvalued or undervalued?

MarketsMojo — Loved in India, Now Global

Dashboard

Poor long term growth as Operating profit has grown by an annual rate 8.76% of over the last 5 years

The company declared negative results in Mar'25 after positive results in Dec'24

With ROCE of 8.55%, it has a very expensive valuation with a 1.93 Enterprise value to Capital Employed

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Integer Holdings Corp. overvalued or undervalued?

Is Integer Holdings Corp. overvalued or undervalued?

Is Integer Holdings Corp. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Integer Holdings Corp.

Company Coordinates